The Outsourcing Facilities Association and compounding pharmacy FarmaKeio Superior Custom Compounding filed a lawsuit following the FDA’s initial announcement, arguing that the shortages were ongoing and that the decision would limit access to essential medicines.
After reevaluating the situation, the agency said it does not plan to take action against compounding pharmacies that violate the law requiring a drug’s inclusion on the FDA shortage list for compounding.
Tirzepatide, the main ingredient of both medicines, fell into short supply because of high demand. Similar GLP-1 medications — semaglutide (Ozempic, Rybelsus, Wegovy), liraglutide (Saxenda, Victoza) and dulaglutide (Trulicity) — remain on the FDA’s drug shortage list.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
